We are live on ! Find out more
LXRX icon

Lexicon Pharmaceuticals
LXRX

104 hedge funds and large institutions have $657M invested in Lexicon Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 27 increasing their positions, 32 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 7

5% more funds holding

Funds holding: 99 → 104 (+5)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

12% less capital invested

Capital invested by funds: $749M → $657M (-$92.3M)

16% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 32

Holders
104
Holders Change
+5
Holders Change %
+5.05%
% of All Funds
3.02%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
12
Increased
27
Reduced
32
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
UBS AM
UBS AM
Illinois
+$6.1M
2
TRSOTSOK
Teachers Retirement System of the State of Kentucky
Kentucky
+$778K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$186K
4
Bank of New York Mellon
Bank of New York Mellon
New York
+$167K
5
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
+$131K

Top Sellers

1
Norges Bank
Norges Bank
Norway
-$3.87M
2
Axa
Axa
France
-$725K
3
Deutsche Bank
Deutsche Bank
Germany
-$380K
4
TA
Teton Advisors
New York
-$302K
5
Bank of America
Bank of America
North Carolina
-$260K
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
1
Artal Group
Luxembourg
$357M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$109M -$28.4K -2,657 -0%
UL
3
Ulys LLC
New York
$42M – – –
UBS AM
4
UBS AM
Illinois
$33.1M +$6.1M +571,580 +21%
Vanguard Group
5
Vanguard Group
Pennsylvania
$20.8M +$186K +17,453 +0.8%
NMC
6
NEA Management Company
Maryland
$16.5M – – –
BFA
7
BlackRock Fund Advisors
California
$15.8M +$103K +9,645 +0.6%
BIT
8
BlackRock Institutional Trust
California
$10.4M +$7.57K +709 +0.1%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$8.67M +$34.3K +3,214 +0.4%
State Street
10
State Street
Massachusetts
$5.11M +$54.6K +5,113 +1%
Schroder Investment Management Group
11
Schroder Investment Management Group
United Kingdom
$4.29M -$171K -15,972 -4%
RA
12
Royce & Associates
New York
$3.86M -$229K -21,429 -5%
TRSOTSOK
13
Teachers Retirement System of the State of Kentucky
Kentucky
$3.66M +$778K +72,814 +24%
Northern Trust
14
Northern Trust
Illinois
$3.63M -$104K -9,724 -3%
Norges Bank
15
Norges Bank
Norway
$3.58M -$3.87M -362,449 -50%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$2.47M +$48.2K +4,514 +2%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$1.88M +$167K +15,679 +9%
TCIM
18
TIAA CREF Investment Management
New York
$1.23M -$21.6K -2,019 -2%
BIM
19
BlackRock Investment Management
Delaware
$908K +$10.5K +983 +1%
Charles Schwab
20
Charles Schwab
California
$840K -$92.7K -8,681 -9%
Royal London Asset Management
21
Royal London Asset Management
United Kingdom
$723K – – –
AllianceBernstein
22
AllianceBernstein
Tennessee
$686K -$13.9K -1,300 -2%
California Public Employees Retirement System
23
California Public Employees Retirement System
California
$659K – – –
GF
24
Gabelli Funds
New York
$637K – – –
California State Teachers Retirement System (CalSTRS)
25
California State Teachers Retirement System (CalSTRS)
California
$595K +$7.17K +671 +1%
1
2 3 4 5

LXRX Hedge Fund Activity: Q3 2014 in Review

104 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Lexicon Pharmaceuticals (LXRX) for Q3 2014, worth a combined $657M — down 12% from $749M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new LXRX positions and 7 closed out — a net gain of 5 holders — while 27 added to existing stakes and 32 trimmed.

The largest buyer was UBS AM, adding an estimated $6.1M. The largest seller was Norges Bank, cutting an estimated $3.87M.

  • 104 institutional investors held Lexicon Pharmaceuticals (LXRX) as of Q3 2014, up from 99 in Q2 2014.
  • Funds reported $657M of Lexicon Pharmaceuticals stock for Q3 2014, down 12% quarter-over-quarter.
  • 12 funds opened new Lexicon Pharmaceuticals positions in Q3 2014 and 7 closed out, a net change of +5 holders.
  • The largest Lexicon Pharmaceuticals buyer in Q3 2014 was UBS AM, an estimated $6.1M added.
  • The largest Lexicon Pharmaceuticals seller in Q3 2014 was Norges Bank, an estimated $3.87M sold.

Based on aggregated 13F filings for Q3 2014.